Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Tarning

Showing results (171-180 of 248) with videos related to

Pageof 25
Sort By:
The Journal of Antimicrobial Chemotherapy|February 10, 2012
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Violet Okaba-Kayom, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 22, 2026
Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi MalariaThanaporn Wattanakul, Daniel J Cooper, Katherine Plewes, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2022
Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIVClifford G Banda, Dumisile Nkosi, Elizabeth Allen, et al.
Clinical Pharmacology and Therapeutics|June 2, 2019
Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether-Lumefantrine for Uncomplicated MalariaPalang Chotsiri, Lise Denoeud-Ndam, Elisabeth Baudin, et al.
BMC Medicine|July 2, 2025
Single low dose primaquine to block the transmission of Plasmodium falciparum-proposed stand-alone and ACT-adapted regimensWalter R J Taylor, Peter Olupot-Olupot, Marie A Onyamboko, et al.
Malaria Journal|March 24, 2018
Acidosis and acute kidney injury in severe malariaNatthida Sriboonvorakul, Aniruddha Ghose, M Mahtab Uddin Hassan, et al.
The Journal of Infectious Diseases|December 20, 2018
Identifying the Components of Acidosis in Patients With Severe Plasmodium falciparum Malaria Using MetabolomicsStije J Leopold, Aniruddha Ghose, Erik L Allman, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2012
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Jonathan Mayito, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2019
A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in AfricaMarie A Onyamboko, Richard M Hoglund, Sue J Lee, et al.
Scientific Reports|May 1, 2019
Amino acid derangements in adults with severe falciparum malariaStije J Leopold, Siribha Apinan, Aniruddha Ghose, et al.
Pageof 25

Showing results (171-180 of 248) with videos related to

Sort By:
Pageof 25
The Journal of Antimicrobial Chemotherapy|February 10, 2012
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Violet Okaba-Kayom, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 22, 2026
Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi MalariaThanaporn Wattanakul, Daniel J Cooper, Katherine Plewes, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2022
Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIVClifford G Banda, Dumisile Nkosi, Elizabeth Allen, et al.
Clinical Pharmacology and Therapeutics|June 2, 2019
Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether-Lumefantrine for Uncomplicated MalariaPalang Chotsiri, Lise Denoeud-Ndam, Elisabeth Baudin, et al.
BMC Medicine|July 2, 2025
Single low dose primaquine to block the transmission of Plasmodium falciparum-proposed stand-alone and ACT-adapted regimensWalter R J Taylor, Peter Olupot-Olupot, Marie A Onyamboko, et al.
Malaria Journal|March 24, 2018
Acidosis and acute kidney injury in severe malariaNatthida Sriboonvorakul, Aniruddha Ghose, M Mahtab Uddin Hassan, et al.
The Journal of Infectious Diseases|December 20, 2018
Identifying the Components of Acidosis in Patients With Severe Plasmodium falciparum Malaria Using MetabolomicsStije J Leopold, Aniruddha Ghose, Erik L Allman, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2012
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Jonathan Mayito, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2019
A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in AfricaMarie A Onyamboko, Richard M Hoglund, Sue J Lee, et al.
Scientific Reports|May 1, 2019
Amino acid derangements in adults with severe falciparum malariaStije J Leopold, Siribha Apinan, Aniruddha Ghose, et al.
Pageof 25